Cite
MLA Citation
Ananth Shankar et al.. “Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma.” European journal of cancer, vol. 158, 2021, pp. 38–46. http://access.bl.uk/ark:/81055/vdc_100145644463.0x00002a